Surufatinib

4 registered clinical trials studyying Surufatinib — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advance NCT07086456	Sun Yat-sen University	Phase 2
Recruiting	Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients NCT07086469	Sun Yat-sen University	Phase 2
Recruiting	Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small NCT06719700	Sun Yat-sen University	Phase 2
Unknown	Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer NCT06134193	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 2